VIRIDIAN THERAPEUTICS INC (VRDN) Stock Cash Flow
NASDAQ:VRDN - Nasdaq - US92790C1045 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -308.32M | -269.95M | -237.73M | -129.87M | -79.41M | |||
| Depreciation Amortization | 512.00K | 540.00K | 522.00K | 260.00K | 120.00K | |||
| Change In Working Capital | 701.00K | 9.60M | -9.43M | 15.96M | 1.72M | |||
| Interest Paid | 1.82M | 1.82M | 886.00K | 290.00K | 0.00 | |||
| Other non cash items | 27.36M | 27.49M | 62.47M | 19.82M | 22.99M | |||
| OPERATING CASH FLOW | -279.75M | -232.32M | -184.17M | -93.84M | -54.58M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -597.00K | -511.00K | -898.00K | -800.00K | -340.00K | |||
| Other Investing Activity | 15.05M | -228.14M | -93.35M | -114.33M | -73.95M | |||
| INVESTING CASH FLOW | 14.46M | -228.65M | -94.25M | -115.13M | -74.29M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 15.00M | 4.55M | 0.00 | |||
| Stock Issued/Repurchased | 305.76M | 484.00M | 217.82M | 336.58M | 132.22M | |||
| Other Financing Activity | -15.89M | -26.27M | -7.15M | -18.89M | -6.95M | |||
| FINANCING CASH FLOW | 289.87M | 457.74M | 225.67M | 322.24M | 125.28M | |||
| CHANGE IN CASH | 24.57M | -3.23M | -52.75M | 113.27M | -3.59M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -279.75M | -232.32M | -184.17M | -93.84M | -54.58M | |||
| Capital Expenditure | -597.00K | -511.00K | -898.00K | -800.00K | -340.00K | |||
| FREE CASH FLOW | -280.35M | -232.83M | -185.07M | -94.64M | -54.92M | |||
All data in USD